The Lp(a) Journey
Professor Henry Ginsberg, Co-Chair of the Lp(a) Forum, looks at progress in Lp(a) science that has led to multiple Lp(a) targeting agents in development.
The Unanswered Questions
Professor John Chapman, Co-Chair of the Lp(a) Forum, considers key questions about Lp(a) atherogenicity, including the heterogeneity of the Lp(a) proteome and lipidome.
Who’s who in the Lp(a) proteome?
Professor Sally McCormick, University of Otago, New Zealand, discusses key research that has provided important insights into the role of the Lp(a) proteome.
